SLC2A2 Mutations Can Cause Neonatal Diabetes, Suggesting GLUT2 May Have a Role in Human Insulin Secretion

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2012 Jun 5

PMID 22660720

Citations 55

Authors

F H Sansbury

S E Flanagan

J A L Houghton

F L Shuixian Shen

A M S Al-Senani

A M Habeb

M Abdullah

A Kariminejad

S Ellard

A T Hattersley

Affiliations

Soon will be listed here.

Abstract

Aims: The gene SLC2A2 encodes GLUT2, which is found predominantly in pancreas, liver, kidney and intestine. In mice, GLUT2 is the major glucose transporter into pancreatic beta cells, and biallelic Slc2a2 inactivation causes lethal neonatal diabetes. The role of GLUT2 in human beta cells is controversial, and biallelic SLC2A2 mutations cause Fanconi-Bickel syndrome (FBS), with diabetes rarely reported. We investigated the potential role of GLUT2 in the neonatal period by testing whether SLC2A2 mutations can present with neonatal diabetes before the clinical features of FBS appear.

Methods: We studied SLC2A2 in patients with transient neonatal diabetes mellitus (TNDM; n = 25) or permanent neonatal diabetes mellitus (PNDM; n = 79) in whom we had excluded the common genetic causes of neonatal diabetes, using a combined approach of sequencing and homozygosity mapping.

Results: Of 104 patients, five (5%) were found to have homozygous SLC2A2 mutations, including four novel mutations (S203R, M376R, c.963+1G>A, F114LfsX16). Four out of five patients with SLC2A2 mutations presented with isolated diabetes and later developed features of FBS. Four out of five patients had TNDM (16% of our TNDM cohort of unknown aetiology). One patient with PNDM remains on insulin at 28 months.

Conclusions: SLC2A2 mutations are an autosomal recessive cause of neonatal diabetes that should be considered in consanguineous families or those with TNDM, after excluding common causes, even in the absence of features of FBS. The finding that patients with homozygous SLC2A2 mutations can have neonatal diabetes supports a role for GLUT2 in the human beta cell.

Citing Articles

New insights into the mechanisms of iron absorption: Iron dextran uptake in the intestines of weaned pigs through glucose transporter 5 (GLUT5) and divalent metal transporter 1 (DMT1) transporters.

Deng S, Yang W, Fang C, He H, Liu J, Fang R Anim Nutr. 2024; 19:25-40.

PMID: 39628646 PMC: 11612655. DOI: 10.1016/j.aninu.2024.05.006.

Genetic variant profiling of neonatal diabetes mellitus in Iranian patients: Unveiling 58 distinct variants in 14 genes.

Mianesaz H, Ghalamkari S, Abbasi F, Razzaghy-Azar M, Sayarifard F, Vakili R J Diabetes Investig. 2024; 15(10):1390-1402.

PMID: 38970407 PMC: 11442839. DOI: 10.1111/jdi.14254.

Predicting type 2 diabetes via machine learning integration of multiple omics from human pancreatic islets.

Ronn T, Perfilyev A, Oskolkov N, Ling C Sci Rep. 2024; 14(1):14637.

PMID: 38918439 PMC: 11199577. DOI: 10.1038/s41598-024-64846-3.

Glucose Transporters Are Key Components of the Human Glucostat.

Caspi I, Tremmel D, Pulecio J, Yang D, Liu D, Yan J Diabetes. 2024; 73(8):1336-1351.

PMID: 38775784 PMC: 11262048. DOI: 10.2337/db23-0508.

Endocrine involvement in hepatic glycogen storage diseases: pathophysiology and implications for care.

Rossi A, Simeoli C, Pivonello R, Salerno M, Rosano C, Brunetti B Rev Endocr Metab Disord. 2024; 25(4):707-725.

PMID: 38556561 PMC: 11294274. DOI: 10.1007/s11154-024-09880-2.

References

MacDonald P, Joseph J, Rorsman P . Glucose-sensing mechanisms in pancreatic beta-cells. Philos Trans R Soc Lond B Biol Sci. 2005; 360(1464):2211-25. PMC: 1569593. DOI: 10.1098/rstb.2005.1762. View

Guillam M, Dupraz P, Thorens B . Glucose uptake, utilization, and signaling in GLUT2-null islets. Diabetes. 2000; 49(9):1485-91. DOI: 10.2337/diabetes.49.9.1485. View

McCulloch L, van de Bunt M, Braun M, Frayn K, Clark A, Gloyn A . GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic beta cells: implications for understanding genetic association signals at this locus. Mol Genet Metab. 2011; 104(4):648-53. DOI: 10.1016/j.ymgme.2011.08.026. View

Santer R, Schneppenheim R, Dombrowski A, Gotze H, Steinmann B, Schaub J . Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi-Bickel syndrome. Nat Genet. 1997; 17(3):324-6. DOI: 10.1038/ng1197-324. View

Murphy R, Ellard S, Hattersley A . Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes. Nat Clin Pract Endocrinol Metab. 2008; 4(4):200-13. DOI: 10.1038/ncpendmet0778. View

Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson A . New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010; 42(2):105-16. PMC: 3018764. DOI: 10.1038/ng.520. View

Thorens B, Cheng Z, Brown D, Lodish H . Liver glucose transporter: a basolateral protein in hepatocytes and intestine and kidney cells. Am J Physiol. 1990; 259(6 Pt 1):C279-85. DOI: 10.1152/ajpcell.1990.259.2.C279. View

Yoo H, Shin Y, Seo E, Kim G . Identification of a novel mutation in the GLUT2 gene in a patient with Fanconi-Bickel syndrome presenting with neonatal diabetes mellitus and galactosaemia. Eur J Pediatr. 2002; 161(6):351-3. DOI: 10.1007/s00431-002-0931-y. View

Chesney R, Kaplan B, Colle E, Scriver C, McInnes R, Dupont C . Abnormalities of carbohydrate metabolism in idiopathic Fanconi syndrome. Pediatr Res. 1980; 14(3):209-15. DOI: 10.1203/00006450-198003000-00006. View

10.

Hughes S, Quaade C, Johnson J, Ferber S, Newgard C . Transfection of AtT-20ins cells with GLUT-2 but not GLUT-1 confers glucose-stimulated insulin secretion. Relationship to glucose metabolism. J Biol Chem. 1993; 268(20):15205-12. View

11.

Habeb A, Al-Magamsi M, Eid I, Ali M, Hattersley A, Hussain K . Incidence, genetics, and clinical phenotype of permanent neonatal diabetes mellitus in northwest Saudi Arabia. Pediatr Diabetes. 2011; 13(6):499-505. DOI: 10.1111/j.1399-5448.2011.00828.x. View

12.

Santer R, Steinmann B, Schaub J . Fanconi-Bickel syndrome--a congenital defect of facilitative glucose transport. Curr Mol Med. 2002; 2(2):213-27. DOI: 10.2174/1566524024605743. View

13.

Seidner G, Alvarez M, Yeh J, ODriscoll K, Klepper J, Stump T . GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet. 1998; 18(2):188-91. DOI: 10.1038/ng0298-188. View

14.

Leturque A, Brot-Laroche E, Le Gall M . GLUT2 mutations, translocation, and receptor function in diet sugar managing. Am J Physiol Endocrinol Metab. 2009; 296(5):E985-92. DOI: 10.1152/ajpendo.00004.2009. View

15.

Baroni M, Sentinelli F, Massa O, Romeo S, Colombo C, Di Mario U . Single-strand conformation polymorphism analysis of the glucose transporter gene GLUT1 in maturity-onset diabetes of the young. J Mol Med (Berl). 2001; 79(5-6):270-4. DOI: 10.1007/s001090100220. View

16.

de Vos A, Heimberg H, Quartier E, Huypens P, Bouwens L, Pipeleers D . Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest. 1995; 96(5):2489-95. PMC: 185903. DOI: 10.1172/JCI118308. View

17.

Whitesell R, Powers A, REGEN D, Abumrad N . Transport and metabolism of glucose in an insulin-secreting cell line, beta TC-1. Biochemistry. 1991; 30(49):11560-6. DOI: 10.1021/bi00113a011. View

18.

GARTY R, Cooper M, Tabachnik E . The Fanconi syndrome associated with hepatic glycogenosis and abnormal metabolism of galactose. J Pediatr. 1974; 85(6):821-3. DOI: 10.1016/s0022-3476(74)80351-3. View

19.

Brown G . Glucose transporters: structure, function and consequences of deficiency. J Inherit Metab Dis. 2000; 23(3):237-46. DOI: 10.1023/a:1005632012591. View

20.

Manz F, Bickel H, BRODEHL J, FEIST D, GELLISSEN K, Gilli G . Fanconi-Bickel syndrome. Pediatr Nephrol. 1987; 1(3):509-18. DOI: 10.1007/BF00849262. View